Tags: Drug.

Levosimendan (INN) /ˌliːvoʊsaɪˈmɛndən/ is a calcium sensitiser used in the management of acutely decompensated congestive heart failure. It is marketed under the trade name Simdax (Orion Corporation).

Levosimendan.svg
ATC prefix
C01
ATC suffix
CX08
Bioavailability
85.0
CAS number
141505-33-1
ChEBI
50567
DrugBank
DB00922
FDA UNII code
C6T4514L4E
IUPAC name
(4-[(4'R'')-4-Methyl-6-oxo-1456-tetrahydropyridazin-3-yl]phenylhydrazono)propanedinitrile
PubChem
3033825

Loading...

This page contains content from the copyrighted Wikipedia article "Levosimendan"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.